HEADER HYDROLASE 25-OCT-21 7SLY TITLE VANIN-1 COMPLEXED WITH COMPOUND 27 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANTETHEINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PANTETHEINE HYDROLASE,TIFF66,VASCULAR NON-INFLAMMATORY COMPND 5 MOLECULE 1,VANIN-1; COMPND 6 EC: 3.5.1.92; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: VNN1; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS PANTETHEINE, SBDD, PYRIMDINE CARBOXAMIDE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR F.F.VAJDOS REVDAT 3 03-APR-24 7SLY 1 REMARK REVDAT 2 26-JAN-22 7SLY 1 JRNL REVDAT 1 12-JAN-22 7SLY 0 JRNL AUTH A.CASIMIRO-GARCIA,C.ALLAIS,A.BRENNAN,C.CHOI,G.DOWER, JRNL AUTH 2 K.A.FARLEY,M.FLEMING,A.FLICK,R.K.FRISBIE,J.HALL,D.HEPWORTH, JRNL AUTH 3 H.JONES,J.D.KNAFELS,S.KORTUM,F.E.LOVERING,J.P.MATHIAS, JRNL AUTH 4 S.MOHAN,P.M.MORGAN,C.PARNG,K.PARRIS,N.PULLEN,F.SCHLERMAN, JRNL AUTH 5 J.STANSFIELD,J.W.STROHBACH,F.F.VAJDOS,F.VINCENT,H.WANG, JRNL AUTH 6 X.WANG,R.WEBSTER,S.W.WRIGHT JRNL TITL DISCOVERY OF A SERIES OF PYRIMIDINE CARBOXAMIDES AS JRNL TITL 2 INHIBITORS OF VANIN-1. JRNL REF J.MED.CHEM. V. 65 757 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 34967602 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01849 REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 28418 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1436 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.25 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.82 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2774 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2454 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2635 REMARK 3 BIN R VALUE (WORKING SET) : 0.2434 REMARK 3 BIN FREE R VALUE : 0.2822 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3622 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 166 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.82540 REMARK 3 B22 (A**2) : -22.82780 REMARK 3 B33 (A**2) : 22.00250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.306 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.229 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.178 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.229 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.179 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3927 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5394 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1331 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 95 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 580 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3927 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 544 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4458 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.25 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.98 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7SLY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000260723. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : 6.1-6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28458 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.170 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.78000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: INTERNAL MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 6.1-6.7, 22-33% PEG-MME REMARK 280 -2000, 10 MM TCEP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.49000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.48650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 73.94250 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.49000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.48650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 73.94250 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.49000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.48650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 73.94250 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.49000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.48650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.94250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -19 REMARK 465 SER A -18 REMARK 465 GLY A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 GLY A -10 REMARK 465 SER A -9 REMARK 465 GLY A -8 REMARK 465 ASP A -7 REMARK 465 TYR A -6 REMARK 465 LYS A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 LYS A 0 REMARK 465 GLN A 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 18 141.26 59.29 REMARK 500 THR A 19 -93.20 -146.16 REMARK 500 LEU A 20 -78.95 51.21 REMARK 500 ASN A 84 79.91 61.74 REMARK 500 GLU A 164 57.68 -97.31 REMARK 500 CYS A 190 -114.64 45.97 REMARK 500 TYR A 248 76.00 -151.25 REMARK 500 THR A 254 132.21 -175.05 REMARK 500 ALA A 291 78.35 -69.04 REMARK 500 SER A 297 -74.61 -50.03 REMARK 500 LYS A 338 -127.27 52.08 REMARK 500 ALA A 427 71.24 -113.98 REMARK 500 REMARK 500 REMARK: NULL DBREF 7SLY A 1 462 UNP O95497 VNN1_HUMAN 22 483 SEQADV 7SLY GLY A -19 UNP O95497 EXPRESSION TAG SEQADV 7SLY SER A -18 UNP O95497 EXPRESSION TAG SEQADV 7SLY GLY A -17 UNP O95497 EXPRESSION TAG SEQADV 7SLY HIS A -16 UNP O95497 EXPRESSION TAG SEQADV 7SLY HIS A -15 UNP O95497 EXPRESSION TAG SEQADV 7SLY HIS A -14 UNP O95497 EXPRESSION TAG SEQADV 7SLY HIS A -13 UNP O95497 EXPRESSION TAG SEQADV 7SLY HIS A -12 UNP O95497 EXPRESSION TAG SEQADV 7SLY HIS A -11 UNP O95497 EXPRESSION TAG SEQADV 7SLY GLY A -10 UNP O95497 EXPRESSION TAG SEQADV 7SLY SER A -9 UNP O95497 EXPRESSION TAG SEQADV 7SLY GLY A -8 UNP O95497 EXPRESSION TAG SEQADV 7SLY ASP A -7 UNP O95497 EXPRESSION TAG SEQADV 7SLY TYR A -6 UNP O95497 EXPRESSION TAG SEQADV 7SLY LYS A -5 UNP O95497 EXPRESSION TAG SEQADV 7SLY ASP A -4 UNP O95497 EXPRESSION TAG SEQADV 7SLY ASP A -3 UNP O95497 EXPRESSION TAG SEQADV 7SLY ASP A -2 UNP O95497 EXPRESSION TAG SEQADV 7SLY ASP A -1 UNP O95497 EXPRESSION TAG SEQADV 7SLY LYS A 0 UNP O95497 EXPRESSION TAG SEQRES 1 A 482 GLY SER GLY HIS HIS HIS HIS HIS HIS GLY SER GLY ASP SEQRES 2 A 482 TYR LYS ASP ASP ASP ASP LYS GLN ASP THR PHE THR ALA SEQRES 3 A 482 ALA VAL TYR GLU HIS ALA ALA ILE LEU PRO ASN ALA THR SEQRES 4 A 482 LEU THR PRO VAL SER ARG GLU GLU ALA LEU ALA LEU MET SEQRES 5 A 482 ASN ARG ASN LEU ASP ILE LEU GLU GLY ALA ILE THR SER SEQRES 6 A 482 ALA ALA ASP GLN GLY ALA HIS ILE ILE VAL THR PRO GLU SEQRES 7 A 482 ASP ALA ILE TYR GLY TRP ASN PHE ASN ARG ASP SER LEU SEQRES 8 A 482 TYR PRO TYR LEU GLU ASP ILE PRO ASP PRO GLU VAL ASN SEQRES 9 A 482 TRP ILE PRO CYS ASN ASN ARG ASN ARG PHE GLY GLN THR SEQRES 10 A 482 PRO VAL GLN GLU ARG LEU SER CYS LEU ALA LYS ASN ASN SEQRES 11 A 482 SER ILE TYR VAL VAL ALA ASN ILE GLY ASP LYS LYS PRO SEQRES 12 A 482 CYS ASP THR SER ASP PRO GLN CYS PRO PRO ASP GLY ARG SEQRES 13 A 482 TYR GLN TYR ASN THR ASP VAL VAL PHE ASP SER GLN GLY SEQRES 14 A 482 LYS LEU VAL ALA ARG TYR HIS LYS GLN ASN LEU PHE MET SEQRES 15 A 482 GLY GLU ASN GLN PHE ASN VAL PRO LYS GLU PRO GLU ILE SEQRES 16 A 482 VAL THR PHE ASN THR THR PHE GLY SER PHE GLY ILE PHE SEQRES 17 A 482 THR CYS PHE ASP ILE LEU PHE HIS ASP PRO ALA VAL THR SEQRES 18 A 482 LEU VAL LYS ASP PHE HIS VAL ASP THR ILE VAL PHE PRO SEQRES 19 A 482 THR ALA TRP MET ASN VAL LEU PRO HIS LEU SER ALA VAL SEQRES 20 A 482 GLU PHE HIS SER ALA TRP ALA MET GLY MET ARG VAL ASN SEQRES 21 A 482 PHE LEU ALA SER ASN ILE HIS TYR PRO SER LYS LYS MET SEQRES 22 A 482 THR GLY SER GLY ILE TYR ALA PRO ASN SER SER ARG ALA SEQRES 23 A 482 PHE HIS TYR ASP MET LYS THR GLU GLU GLY LYS LEU LEU SEQRES 24 A 482 LEU SER GLN LEU ASP SER HIS PRO SER HIS SER ALA VAL SEQRES 25 A 482 VAL ASN TRP THR SER TYR ALA SER SER ILE GLU ALA LEU SEQRES 26 A 482 SER SER GLY ASN LYS GLU PHE LYS GLY THR VAL PHE PHE SEQRES 27 A 482 ASP GLU PHE THR PHE VAL LYS LEU THR GLY VAL ALA GLY SEQRES 28 A 482 ASN TYR THR VAL CYS GLN LYS ASP LEU CYS CYS HIS LEU SEQRES 29 A 482 SER TYR LYS MET SER GLU ASN ILE PRO ASN GLU VAL TYR SEQRES 30 A 482 ALA LEU GLY ALA PHE ASP GLY LEU HIS THR VAL GLU GLY SEQRES 31 A 482 ARG TYR TYR LEU GLN ILE CYS THR LEU LEU LYS CYS LYS SEQRES 32 A 482 THR THR ASN LEU ASN THR CYS GLY ASP SER ALA GLU THR SEQRES 33 A 482 ALA SER THR ARG PHE GLU MET PHE SER LEU SER GLY THR SEQRES 34 A 482 PHE GLY THR GLN TYR VAL PHE PRO GLU VAL LEU LEU SER SEQRES 35 A 482 GLU ASN GLN LEU ALA PRO GLY GLU PHE GLN VAL SER THR SEQRES 36 A 482 ASP GLY ARG LEU PHE SER LEU LYS PRO THR SER GLY PRO SEQRES 37 A 482 VAL LEU THR VAL THR LEU PHE GLY ARG LEU TYR GLU LYS SEQRES 38 A 482 ASP HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET BMA D 4 11 HET BMA D 5 11 HET BMA D 6 11 HET NAG A 501 14 HET 9S5 A 502 51 HET NAG A 503 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM 9S5 (8-OXA-2-AZASPIRO[4.5]DECAN-2-YL)(2-{[(1S)-1-(PYRAZIN- HETNAM 2 9S5 2-YL)ETHYL]AMINO}PYRIMIDIN-5-YL)METHANONE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 6(C8 H15 N O6) FORMUL 2 BMA 5(C6 H12 O6) FORMUL 5 9S5 C19 H24 N6 O2 FORMUL 7 HOH *118(H2 O) HELIX 1 AA1 SER A 24 GLN A 49 1 26 HELIX 2 AA2 ASN A 67 TYR A 72 1 6 HELIX 3 AA3 PRO A 73 LEU A 75 5 3 HELIX 4 AA4 ASP A 80 ASN A 84 5 5 HELIX 5 AA5 THR A 97 SER A 111 1 15 HELIX 6 AA6 THR A 189 PHE A 195 5 7 HELIX 7 AA7 PRO A 198 ASP A 205 1 8 HELIX 8 AA8 SER A 225 ARG A 238 1 14 HELIX 9 AA9 TYR A 248 LYS A 252 5 5 HELIX 10 AB1 THR A 296 ILE A 302 1 7 HELIX 11 AB2 ASN A 386 CYS A 390 5 5 HELIX 12 AB3 TYR A 459 ASP A 462 5 4 SHEET 1 AA1 6 LEU A 151 HIS A 156 0 SHEET 2 AA1 6 ARG A 136 PHE A 145 -1 N VAL A 144 O VAL A 152 SHEET 3 AA1 6 TYR A 113 PRO A 123 -1 N ALA A 116 O VAL A 143 SHEET 4 AA1 6 ILE A 53 VAL A 55 1 N ILE A 54 O VAL A 115 SHEET 5 AA1 6 THR A 3 GLU A 10 1 N TYR A 9 O VAL A 55 SHEET 6 AA1 6 LYS A 277 ASP A 284 -1 O LEU A 279 N VAL A 8 SHEET 1 AA2 6 THR A 177 THR A 180 0 SHEET 2 AA2 6 GLY A 183 ILE A 187 -1 O PHE A 185 N PHE A 178 SHEET 3 AA2 6 THR A 210 THR A 215 1 O THR A 210 N GLY A 186 SHEET 4 AA2 6 ASN A 240 ASN A 245 1 O LEU A 242 N ILE A 211 SHEET 5 AA2 6 SER A 256 TYR A 259 -1 O TYR A 259 N PHE A 241 SHEET 6 AA2 6 SER A 264 HIS A 268 -1 O ALA A 266 N ILE A 258 SHEET 1 AA3 7 GLU A 311 VAL A 316 0 SHEET 2 AA3 7 ASP A 319 LYS A 325 -1 O PHE A 323 N PHE A 312 SHEET 3 AA3 7 TYR A 357 HIS A 366 -1 O LEU A 359 N VAL A 324 SHEET 4 AA3 7 TYR A 372 LYS A 381 -1 O TYR A 372 N HIS A 366 SHEET 5 AA3 7 VAL A 449 ARG A 457 -1 O VAL A 452 N LEU A 379 SHEET 6 AA3 7 VAL A 415 LEU A 421 -1 N PHE A 416 O PHE A 455 SHEET 7 AA3 7 GLN A 425 LEU A 426 -1 O GLN A 425 N LEU A 421 SHEET 1 AA4 5 ALA A 330 GLN A 337 0 SHEET 2 AA4 5 LEU A 340 MET A 348 -1 O CYS A 342 N VAL A 335 SHEET 3 AA4 5 PHE A 401 GLY A 408 -1 O SER A 407 N HIS A 343 SHEET 4 AA4 5 LEU A 439 SER A 441 -1 O LEU A 439 N LEU A 406 SHEET 5 AA4 5 PHE A 431 VAL A 433 -1 N GLN A 432 O PHE A 440 SSBOND 1 CYS A 88 CYS A 105 1555 1555 2.05 SSBOND 2 CYS A 124 CYS A 131 1555 1555 2.04 SSBOND 3 CYS A 336 CYS A 341 1555 1555 2.06 SSBOND 4 CYS A 342 CYS A 377 1555 1555 2.06 SSBOND 5 CYS A 382 CYS A 390 1555 1555 2.04 LINK ND2 ASN A 109 C1 NAG A 501 1555 1555 1.43 LINK ND2 ASN A 179 C1 NAG D 1 1555 1555 1.43 LINK ND2 ASN A 294 C1 NAG B 1 1555 1555 1.43 LINK ND2 ASN A 332 C1 NAG A 503 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.41 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.41 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.39 LINK O6 BMA D 3 C1 BMA D 4 1555 1555 1.36 LINK O3 BMA D 3 C1 BMA D 6 1555 1555 1.33 LINK O3 BMA D 4 C1 BMA D 5 1555 1555 1.38 CISPEP 1 ALA A 18 THR A 19 0 -3.04 CISPEP 2 ASP A 197 PRO A 198 0 3.04 CISPEP 3 LEU A 221 PRO A 222 0 10.97 CISPEP 4 SER A 422 GLU A 423 0 -4.91 CISPEP 5 PRO A 428 GLY A 429 0 -25.68 CRYST1 64.980 110.973 147.885 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015389 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009011 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006762 0.00000